Women are and will be the predominant users of GLP-1 users, but research gaps remain critical
The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women. The authors, that include Professor Paul Franks, Lund University, Helsingborg Hospital,…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
